Brucellosis Vaccine Market To Reach $387.4 Million Valuation By 2031: TMR

0

Transparency Market Research Inc.: Global brucellosis vaccine market was valued at US$ 253.1 Min in 2020 and is expected to grow at a CAGR of 4% from 2021 to 2031. Brucellosis is a highly transmissible zoonotic infection. Brucella is transmitted from animals to humans through the consumption of infected food, undercooked meat, or unpasteurized milk from diseased animals; direct contact with an infected animal or its offspring, or inhalation of aerosols. Different types of vaccines are available for brucellosis, including the RB51 vaccine and the S19 vaccine. The global brucellosis vaccine market is driven by increasing prevalence of brucellosis and increasing investment by government agencies.

Asia-Pacific dominated the global brucellosis vaccine market in 2020, and the trend is expected to continue during the forecast period. Increasing population, new product launches, high prevalence rate of brucellosis and presence of major players are expected to propel the brucellosis vaccine market in Asia Pacific during the forecast period. Asia-Pacific is likely to be a very lucrative market for brucellosis vaccines during the forecast period. The region market is expected to grow at a high CAGR from 2021 to 2031.

Request a sample report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34439

Increase in the prevalence of brucellosis and increase in investment by government agencies to drive the global market

Rising number of animals suffering from brucellosis is expected to drive the growth of the global brucellosis vaccine market from 2021 to 2031. Globalization and climate change are driving the emergence of animal diseases; some of them are transmissible to humans. According to IFAH Europe, rising global temperatures are leading to the appearance of new diseases and favoring the reappearance of other diseases. Most human zoonotic infections are transmitted by livestock. Zoonotic diseases account for 61% of total animal diseases. Increasing livestock numbers in countries like India and China are expected to drive the demand for brucellosis vaccines in the near future.

Government initiatives play an important role in the growth of the animal health segment. For example, China’s mandatory vaccination policy, availability of affordable veterinary vaccines, awareness programs, and research and development funding are expected to drive the global veterinary healthcare market. The Animal and Plant Health Agency (APHA) has been awarded US$100,000 in the AgResults’ Brucellosis Vaccine Prize competition, aimed at encouraging the development of an effective, safe and viable vaccine for use against Brucella melitensis in young ruminants in the developing world.

RB51 vaccine to dominate brucellosis vaccine market

In terms of type, the global brucellosis vaccine market has been categorized into RB51 vaccine, S19 vaccine and others. The RB51 vaccine segment dominated the global brucellosis vaccine market in 2020, and the trend is expected to continue during the forecast period. The RB51 vaccine is the most commonly used vaccine against brucellosis. Vaccination of pregnant cows with strain RB51 can induce low levels of abortion (less than 0.2%); however, it is safe in lower doses during pregnancy. This is likely to propel the segment during the forecast period. Additionally, increasing preference for RB51 vaccine over others due to its high efficacy at low dose is expected to grow the segment in the coming years.

Inquiry Before Buying- https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=34439

DNA vaccine held significant market share in 2020

On the basis of vaccine type, the global brucellosis vaccine market has been categorized into DNA vaccine, subunit vaccine, vector vaccine, and recombinant vaccine. The DNA vaccines segment dominated the global brucellosis vaccines market in terms of revenue in 2020 and the trend is expected to continue during the forecast period. DNA vaccination has provided a novel and valuable approach for the development of brucellosis vaccines and has offered advantages in terms of design flexibility, speed, simplicity of production, and the ability to elicit cellular and humoral immune responses. This factor is expected to fuel the growth of the segment over the forecast period.

Livestock will be a very lucrative application

In terms of application, the global brucellosis vaccine market has been segregated into cattle, sheep & goats and others. The segment is expected to account for a major market share during the forecast period owing to the high usage of these vaccines for cattle. Additionally, increasing cattle herds in countries like India and Brazil are expected to propel the segment in the coming years. According to a study, Brazil had about 145 million cattle in 2020.

Veterinary hospitals and clinics will be the main distribution channel

On the basis of distribution channel, the global brucellosis vaccine market has been divided into veterinary hospitals and clinics, retail channels and others. Veterinary hospitals and clinics segment dominated the global brucellosis vaccines market in terms of revenue in 2020. The trend is expected to continue during the forecast period owing to the increase in the propensity of owners to avail of various vaccines offered by veterinary clinics and the increase in preference for veterinarians. hospitals and clinics for vaccination.

Asia-Pacific to Dominate the Brucellosis Vaccine Market

In terms of region, the global brucellosis vaccine market has been segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Asia Pacific led the global brucellosis vaccine market in 2020, followed by Europe. The large market share of Asia-Pacific can be attributed to increasing livestock population, increasing brucellosis cases, lower disease awareness, new product launches and presence of major players.

Asia Pacific Brucellosis Vaccine Market is projected to grow at a high CAGR from 2021 to 2031. This can be attributed to the presence of developing countries with trading hubs, expanding business organizations, growing improving healthcare infrastructure and increasing business investment.

Competition landscape

The global brucellosis vaccine market is fragmented due to the presence of a large number of players. The major players operating in the global market are Merck Animal Health, Ceva Santé Animale, CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Fivet Animal Health, Jordan Bio-industries Center, and Laboratories Tornel.

About Us

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, USA, provides custom research and business advisory services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

Contact information:
Name: Rohit Bhisey
Email: Send email
Organization: Transparency Market Research Inc.
Address: DOWNTOWN HEADQUARTERS, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA
Phone: +1-518-618-1030
Website: https://www.transparencymarketresearch.com

Build ID: 89079394

If you detect any problems, problems or errors in the content of this press release, please contact [email protected] to let us know. We will respond and rectify the situation within the next 8 hours.

COMTEX_411376659/2773/2022-08-01T22:48:32

Share.

About Author

Comments are closed.